| Primary information |
|---|
| PRRID | PRRID_0994 |
| Ligand Name | Heplisav (ISS-1018) |
| Source | Dynavax Technologies(others) |
| Sequence of ligand | NA |
| Length | NA |
| Type | CpG ODN + HBV surface antigen |
| Occurence | NA |
| Role of Ligand | Immunostimulant |
| Name of receptor | Toll-like receptor 9 (TLR9) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human |
| Localization | NA |
| Domain | NA |
| Sequence of Receptor | Q9NR96.fasta |
| Swiss prot ID | Q9NR96 |
| Length Of Receptor | 1032 |
| Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
| Assay used | NA |
| PMID | 23017246 |
| Year of Publication | 2012 |
| Pubchem assay | Pubchem Assay |
| Primary information |
|---|
| PRRID | PRRID_0994 |
| Ligand Name | Heplisav (ISS-1018) |
| Source | Dynavax Technologies(others) |
| Sequence of ligand | NA |
| Length | NA |
| Type | CpG ODN + HBV surface antigen |
| Occurence | NA |
| Role of Ligand | Immunostimulant |
| Name of receptor | Toll-like receptor 9 (TLR9) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human |
| Localization | NA |
| Domain | NA |
| Sequence of Receptor | Q9NR96.fasta |
| Swiss prot ID | Q9NR96 |
| Length Of Receptor | 1032 |
| Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
| Assay used | NA |
| PMID | 23017246 |
| Year of Publication | 2012 |
| Pubchem assay | Pubchem Assay |